placeholder newsslider

The European Vision Institute EEIG

European Alliance for the Promotion of Vision Research and Ophthalmology

Blindness is one of the most feared health hazards in our present society; millions of Europeans are threatened by blinding untreatable eye diseases producing costs of several billion Euros. EVI aims at devising and implementing programs and projects for new therapeutic strategies for eye diseases that are difficult or impossible to be treated presently. Its approach will incorporate the most recent scientific developments of the postgenomic area.

The Importance of EVI

The European Vision Institute should be of enormous strategic importance for the future and is targeted towards more immediate policy objectives of improving the competitiveness of European Research assembling the top institutes together with partners from industry and academia. EVI integrates, conducts and supports research that helps to prevent and treat eye diseases and other disorders of vision. This research leads to sight-saving treatments, reduces visual impairment and blindness, and improves the quality of life for people of all ages.

Vision Research in Europe

SIFG „New Technologies for Outcome Measures in Retina and Glaucoma”

Meeting of the European Vision Institute - Special Interest Focus Group „New Technologies for Outcome Measures in Retina and Glaucoma” in Basel, Switzerland from 08. - 09. November 2018 Read more

NIDEK Launches First Automated 360-Degree Gonioscopy Device

NIDEK CO., LTD has announced the launch of the GS-1 Gonioscope device. Read more

Satisfaction in science

Nature’s survey offers a snapshot of salaries and career paths in the scientific sector. Read more

How to work with your institution’s press office to maximize the reach of your work

Want your study to make the headlines? You can get help with that. Read more

Second Sight Raises $5 Million in Private Placement from Chairman Gregg Williams

Second Sight Medical Products entered an agreement with entities beneficially owned by the company’s chairman, Gregg Williams, for the purchase of 3.2 million shares of common stock priced at $1.55 per share, the company announced. Read more

The "Gateway to European Vision Research" is a web-based portal service for the European vision research community and major stakeholders.

The Vision Awards

An award and public recognition by any measure is a sign of inimitability - an acknowledgment that peers and professionals alike agree that a certain person excels in what they do.

Read more about the European Vision Award and the Carl Zeiss Young Investigator Award.